Diabetic retinopathy is a systemic complication of diabetes, meaning the underlying cause (high blood sugar) circulates throughout the entire body and typically affects both eyes. Because the blood vessels in both retinas are exposed to the same metabolic environment, it is rare for the condition to be strictly confined to one eye for a long period. However, while the disease is generally bilateral, the rate of progression and the severity of the damage can vary significantly between the left and right eye. In the United Kingdom, the Diabetic Eye Screening Programme always captures images of both eyes to ensure that any asymmetrical changes are identified and monitored appropriately.
What We’ll Discuss in This Article
- The systemic nature of diabetic retinopathy and its bilateral impact.
- Why the severity of damage can differ between the left and right eye.
- The clinical significance of asymmetrical retinopathy in a diagnosis.
- How diabetic maculopathy may affect one eye more than the other.
- The role of UK screening in monitoring both eyes simultaneously.
- Instances where localized eye conditions might mask or mimic bilateral damage.
The Systemic Basis for Bilateral Involvement
Diabetic retinopathy develops because chronic high blood glucose levels cause damage to the lining of the small blood vessels (capillaries) in the retina. Since these vessels are supplied by the same systemic circulation, they are subjected to the same levels of glucose, blood pressure, and oxidative stress. Consequently, the pathological changes such as microaneurysms, haemorrhages, and exudates usually appear in both eyes.
In the early stages, known as background retinopathy, it is very common for a clinician to find a similar number of small red dots (microaneurysms) in both eyes. According to NHS information on diabetic retinopathy, the condition is categorized as a bilateral disease. If a screening only identifies damage in one eye, it often prompts a closer examination to ensure that very subtle changes in the other eye have not been missed or to investigate if an additional localized factor is influencing the results.
Why Progression Rates May Differ
Although the condition is typically present in both eyes, it does not always progress at the same speed. It is common for one eye to have “pre-proliferative” changes while the other remains in the “background” stage. This asymmetry can occur due to slight variations in the local blood flow of each eye or pre-existing ocular conditions. For example, if one eye has a different internal pressure or a history of unrelated vascular issues, it may be resilient to the effects of diabetes.
A significant difference in severity between the two eyes is something UK ophthalmologists monitor closely. Research published in the British Journal of Ophthalmology suggests that while retinopathy is usually symmetric, significant asymmetry can sometimes be a sign of other vascular problems, such as carotid artery stenosis, where a blockage in a neck artery reduces blood flow (and therefore the delivery of high-sugar blood) to one eye compared to the other.
Asymmetry in Diabetic Maculopathy
Diabetic maculopathy, which involves fluid leakage near the central part of the retina (the macula), is a common cause of vision loss that frequently presents asymmetrically. A patient may experience blurred central vision in one eye due to macular oedema, while the other eye retains clear vision, even if it also has some background retinopathy. This is because the exact location of a leaky blood vessel is somewhat random.
If fluid builds up directly under the macula of the right eye but is located further away in the left eye, the visual impact will be vastly different. In the UK, if maculopathy is detected in either eye, the patient is often referred for an Optical Coherence Tomography (OCT) scan of both eyes. This high-resolution imaging allows clinicians to measure the thickness of the retina in both maculas and determine if treatment, such as anti-VEGF injections, is required for one or both eyes.
Impact on Proliferative Stages
When retinopathy reaches the proliferative stage (Stage 3), where new and fragile blood vessels begin to grow, the risk of sudden vision loss becomes high. This stage also tends to be bilateral, but a vitreous haemorrhage (a bleed into the eye gel) often occurs in one eye at a time. A patient might wake up with sudden floaters or a “curtain” over their vision in one eye, while the other remains clear.
This does not mean the other eye is “safe”; rather, it indicates that both eyes are at a critical stage, but only one has had a vessel rupture so far. UK clinical guidelines from NICE emphasize that if proliferative disease is found in one eye, the other must be treated with equal urgency, often with pan-retinal photocoagulation (laser treatment), to prevent a similar bleed from occurring.
The Importance of Comprehensive Screening
The UK’s systematic screening process is built on the understanding that retinopathy is a two-eye disease. During a screening appointment, drops are often used to dilate the pupils of both eyes so that clear, wide-angle photographs can be taken of both retinas. These images are then “graded” by specialists who look for symmetry or any concerning differences between the two sides.
If the screening results show “R1” (background changes) in both eyes, the patient continues the standard pathway. If one eye shows “R2” (pre-proliferative) and the other “R1”, the patient’s management is dictated by the more advanced eye. This “worst-eye” principle ensures that treatment is never delayed and that the patient receives the highest level of care required to protect their overall sight.
| Feature | Bilateral (Both Eyes) | Asymmetrical (Different) |
| Initial Cause | Always systemic (blood sugar) | Local factors (pressure, blood flow) |
| Early Stages | Very common to see in both | Possible but less frequent |
| Maculopathy | Usually present in both | Visual impact often starts in one |
| Proliferative | New vessels usually grow in both | Rupture/bleed usually starts in one |
| Treatment | Often applied to both eyes | Tailored to the severity of each eye |
Conclusion
Diabetic retinopathy almost always affects both eyes because it is caused by a systemic issue within the bloodstream. While the presence of the disease is usually bilateral, the severity and the timing of vision loss can vary between the two eyes. Regular screening of both eyes is the only way to track these changes and ensure that treatment is applied effectively to prevent permanent damage. If you experience severe, sudden, or worsening symptoms, call 999 immediately.
Can I have retinopathy in one eye and not the other?
It is possible in the very early stages, but because the cause is systemic, it usually appears in both eyes eventually. Significant one-sided retinopathy is rare.
Why is my vision only blurry in one eye?
This is often due to diabetic maculopathy, where fluid has leaked into the central part of the retina in that specific eye, even if the other eye also has diabetes-related damage.
If I have laser treatment in one eye, do I need it in the other?
If the retinopathy is at the same stage in both eyes, clinicians often recommend treating both to prevent future bleeds, though they may be treated on different days.
Does eye surgery like cataract removal affect retinopathy?
Sometimes surgery in one eye can cause a temporary flare-up of retinopathy in that eye, making it appear worse than the untreated eye for a short period.
If one eye is “blind” from retinopathy, can the other be saved?
Yes. Even if one eye has advanced damage, strict management of blood sugar and blood pressure, along with treatment, can often preserve the vision in the remaining eye.
How does high blood pressure affect the symmetry of the disease?
High blood pressure affects both eyes equally, usually reinforcing the bilateral nature of the damage.
Can an eye patch help if one eye is worse?
An eye patch does not treat retinopathy and is generally not recommended unless advised by a specialist for specific coordination or double-vision issues.
Authority Snapshot
This article discusses the bilateral nature of diabetic retinopathy and how it affects both eyes. The content is written in accordance with UK health standards and has been reviewed by Dr. Rebecca Fernandez to ensure alignment with NHS and NICE clinical guidance. Our goal is to help patients understand why both eyes are monitored and how asymmetrical progression is managed within the UK healthcare system.
